Edwards Lifesciences Corporation EW
86.29
0.56
0.65%
as of 25 Sep
- Market cap
- $49.4B
- P/E
- 49.6×
Follow EW
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Edwards Lifesciences Corporation (EW) Net income
Edwards Lifesciences Corporation's net income for fiscal 2025 was $1.1B, down 74.4% from $4.2B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.0B. Over the past ten years it has ranged from $494.9M (fiscal 2015) to $4.2B (fiscal 2024); the current reading is higher than 64% of that period. Edwards Lifesciences Corporation ranks 8th of 149 Medical Devices companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.1B | (74.35%) |
| FY2024 | $4.2B | 197.96% |
| FY2023 | $1.4B | (8.05%) |
| FY2022 | $1.5B | 1.25% |
| FY2021 | $1.5B | 82.55% |
| FY2020 | $823.4M | (21.35%) |
| FY2019 | $1.0B | 44.96% |
| FY2018 | $722.2M | 23.75% |
| FY2017 | $583.6M | 2.48% |
| FY2016 | $569.5M | 15.07% |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $241.4M | (36.59%) |
| Mar 2026 | $380.7M | 317.43% |
| Dec 2025 | $91.2M | (68.58%) |
| Sep 2025 | $290.3M | (12.43%) |
| 42 more quarters | Free account |
Against its own ten years
Low $494.9M
High $4.2B
Ten-year median
$1.0B
Current reading's percentile
64
Net income against peers
| Company | Net income |
|---|---|
| MDT Medtronic PLC compare | $5.3B |
| SYK Stryker Corporation compare | $3.7B |
| BSX Boston Scientific Corporation compare | $3.7B |
| GEHC GE HealthCare Technologies Inc. compare | $2.1B |
| PHG Koninklijke Philips N.V. compare | $1.3B |
| EW Edwards Lifesciences Corporation | $1.0B |
| DXCM DexCom, Inc. compare | $999.7M |
| STE STERIS plc compare | $808.1M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $807.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on EW
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement